{"organizations": [], "uuid": "424ed4f7a83ec95b8f5781a46e53cd6520cc7cdc", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "https://fm.cnbc.com/applications/cnbc.com/resources/img/editorial/2018/05/10/105200645-5ED2-MM-Block-F-051018.600x400.jpg", "site_section": "http://www.cnbc.com/id/10001135/device/rss/rss.html", "section_title": "Stock Picks", "url": "https://www.cnbc.com/video/2018/05/10/biomarin-ceo-our-new-drug-could-change-hemophilia-patients-lives.html", "country": "US", "domain_rank": 767, "title": "Our new drug could drastically change hemophilia patients' lives, BioMarin CEO says", "performance_score": 0, "site": "cnbc.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "blogs", "published": "2018-05-11T02:07:00.000+03:00", "replies_count": 0, "uuid": "424ed4f7a83ec95b8f5781a46e53cd6520cc7cdc"}, "author": "", "url": "https://www.cnbc.com/video/2018/05/10/biomarin-ceo-our-new-drug-could-change-hemophilia-patients-lives.html", "ord_in_thread": 0, "title": "Our new drug could drastically change hemophilia patients' lives, BioMarin CEO says", "locations": [], "entities": {"persons": [{"name": "jim c", "sentiment": "negative"}, {"name": "jean-jacques bienaimé", "sentiment": "none"}, {"name": "ramer", "sentiment": "none"}], "locations": [], "organizations": [{"name": "biomarin", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Our new drug could drastically change hemophilia patients' lives, BioMarin CEO says 12 Hours Ago Jim Cramer hears from BioMarin Chairman and CEO Jean-Jacques Bienaimé, who discusses new products in his company's pipeline.", "external_links": [], "published": "2018-05-11T02:07:00.000+03:00", "crawled": "2018-05-11T04:09:54.073+03:00", "highlightTitle": ""}